Stock Comparison
ABT vs ZBH
Abbott Laboratories and Zimmer Biomet Holdings Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$18.76B
P/E (TTM)
35.7
23.9
Forward P/E
20.0
11.8
Price/Sales
4.1
2.2
Price/Book
3.7
1.5
EV/EBITDA
18.6
11.1
Dividend Yield
1.66%
0.72%
Profitability
Net Margin
13.91%
9.05%
Operating Margin
18.17%
15.61%
Return on Equity
10.60%
6.41%
Return on Assets
5.33%
3.96%
Growth (YoY)
Revenue Growth
13.00%
4.80%
Earnings Growth
-47.50%
33.80%
Price & Risk
Beta
0.6
0.5
52-Week High
$134.48
$106.88
52-Week Low
$82.56
$79.58
Analyst Target
$118.42
$107.57
Compare ABT and ZBH your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.